Twelve-Month Efficacy and Safety of Low-Intensity Shockwave Therapy for Erectile Dysfunction in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors

@inproceedings{Bechara2016TwelveMonthEA,
  title={Twelve-Month Efficacy and Safety of Low-Intensity Shockwave Therapy for Erectile Dysfunction in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors},
  author={Amado Bechara and A. Ricardo Casab{\'e} and Walter De Bonis and Pablo Gomez Ciciclia},
  booktitle={Sexual medicine},
  year={2016}
}
INTRODUCTION Low-intensity shockwave therapy (LISWT) has recently emerged as a promising method in the treatment of erectile dysfunction (ED). AIM To assess the long-term results of the effectiveness and safety of LISWT in patients with ED who are non-responders to phosphodiesterase type 5 inhibitor (PDE5i) treatment. METHODS This open-label, longitudinal, and observational study investigated an uncontrolled population of 50 consecutive patients whose ED was unresponsive to PDE5i treatment… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 17 CITATIONS

A systematic review of the long-term efficacy of low-intensity shockwave therapy for vasculogenic erectile dysfunction

  • International Urology and Nephrology
  • 2019
VIEW 4 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 35 REFERENCES

Safety and efficacy of low intensity shockwave (LISW) treatment in patients with erectile dysfunction

  • International braz j urol : official journal of the Brazilian Society of Urology
  • 2015

Low intensity shock wave therapy in vascular disease and erectile dysfunction: theory and outcomes

IE Gruenwald, N Kitey, B Appel
  • Sex Med Rev 2013;1:83-90
  • 2013